Gabapentin
NDC 81033-123, Gabapentin, solution, from Kesin Pharma Corporation.
- Product NDC
- 81033-123
- Status
- Listed
- Labeler
- Kesin Pharma Corporation
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091286
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81033-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN50 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81033-123-16 | 81033012316 | 473 mL in 1 BOTTLE (81033-123-16) |
| 81033-123-44 | 81033012344 | 40 CUP, UNIT-DOSE in 1 CARTON (81033-123-44) / 5 mL in 1 CUP, UNIT-DOSE (81033-123-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels?ndc=81033-123
Use it
Look up 81033-123 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81033-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81033-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.